These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 36550462)

  • 1. Downregulation of SMIM3 inhibits growth of leukemia via PI3K-AKT signaling pathway and correlates with prognosis of adult acute myeloid leukemia with normal karyotype.
    Liu Y; Chen Y; Liu Y; Li M; Zhang Y; Shi L; Yang L; Li T; Li Y; Jiang Z; Liu Y; Wang C; Wang S
    J Transl Med; 2022 Dec; 20(1):612. PubMed ID: 36550462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of GNA15 Inhibits Cell Proliferation
    Li M; Liu Y; Liu Y; Yang L; Xu Y; Wang W; Jiang Z; Liu Y; Wang S; Wang C
    Front Oncol; 2021; 11():724435. PubMed ID: 34552875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long noncoding RNA LINC00265 predicts the prognosis of acute myeloid leukemia patients and functions as a promoter by activating PI3K-AKT pathway.
    Ma L; Kuai WX; Sun XZ; Lu XC; Yuan YF
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7867-7876. PubMed ID: 30536332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel iheyamine A derivative L42 suppresses acute myeloid leukemia via dual regulation of the PI3K/AKT/FOXO3a axis and TNF signaling pathway.
    Dinghuan W; Yi K; Jianzhi T; Wenfei W; Chunlin W; Anling H; Zhixu H; Ben-David Y; Sheng L; Xiaoyan Y; Xiao X
    Biomed Pharmacother; 2024 Aug; 177():117071. PubMed ID: 38981243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-338-3p Plays a Significant Role in Casticin-Induced Suppression of Acute Myeloid Leukemia via Targeting PI3K/Akt Pathway.
    Yu K; Wang J; Hou J; Zhang L; Liang H
    Biomed Res Int; 2022; 2022():9214130. PubMed ID: 35765408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinesin family member 2A acts as a potential prognostic marker and treatment target via interaction with PI3K/AKT and RhoA/ROCK pathways in acute myeloid leukemia.
    Liang X; Xia R
    Oncol Rep; 2022 Jan; 47(1):. PubMed ID: 34792179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. UBE2C promotes the proliferation of acute myeloid leukemia cells through PI3K/AKT activation.
    Wang L; Zhao S; Wang Y; Liu J; Wang X
    BMC Cancer; 2024 Apr; 24(1):497. PubMed ID: 38637730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CXCL8 derived from mesenchymal stromal cells supports survival and proliferation of acute myeloid leukemia cells through the PI3K/AKT pathway.
    Cheng J; Li Y; Liu S; Jiang Y; Ma J; Wan L; Li Q; Pang T
    FASEB J; 2019 Apr; 33(4):4755-4764. PubMed ID: 30592634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA‑93 knockdown inhibits acute myeloid leukemia cell growth via inactivating the PI3K/AKT pathway by upregulating DAB2.
    Huang J; Xiao R; Wang X; Khadka B; Fang Z; Yu M; Zhang L; Wu J; Liu J
    Int J Oncol; 2021 Oct; 59(4):. PubMed ID: 34476495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor suppressor miR-520a inhibits cell growth by negatively regulating PI3K/AKT signaling pathway in acute myeloid leukemia.
    Xiao J; Wan F; Tian L; Li Y
    Adv Clin Exp Med; 2024 Jul; 33(7):729-738. PubMed ID: 37855060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SEMA4D/PlexinB1 promotes AML progression via activation of PI3K/Akt signaling.
    Liu L; Yang L; Liu X; Liu M; Liu J; Feng X; Nie Z; Luo J
    J Transl Med; 2022 Jul; 20(1):304. PubMed ID: 35794581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prazosin inhibits the proliferation and survival of acute myeloid leukaemia cells through down-regulating TNS1.
    Sun X; Yang S; Song W
    Biomed Pharmacother; 2020 Apr; 124():109731. PubMed ID: 31954876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory role of RBM39 in acute myeloid leukemia: Mediation through the PI3K/AKT pathway.
    Zhang X; Yang L; Liu X; Nie Z; Liu M; Wang T; Lu Y; Pan Y; Zhan Y; Wang Z; Luo J
    Biochim Biophys Acta Mol Cell Res; 2024 Jan; 1871(1):119607. PubMed ID: 37852323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of long noncoding RNA HOXA-AS2 predicts an adverse prognosis and promotes tumorigenesis via SOX4/PI3K/AKT pathway in acute myeloid leukemia.
    Qu Y; Wang Y; Wang P; Lin N; Yan X; Li Y
    Cell Biol Int; 2020 Aug; 44(8):1745-1759. PubMed ID: 32369230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ZEB1 serves as an oncogene in acute myeloid leukaemia via regulating the PTEN/PI3K/AKT signalling pathway by combining with P53.
    Li L; Feng Y; Hu S; Du Y; Xu X; Zhang M; Peng X; Chen F
    J Cell Mol Med; 2021 Jun; 25(11):5295-5304. PubMed ID: 33960640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor suppressor miR-139-5p targets Tspan3 and regulates the progression of acute myeloid leukemia through the PI3K/Akt pathway.
    Zhang R; Tang P; Wang F; Xing Y; Jiang Z; Chen S; Meng X; Liu L; Cao W; Zhao H; Ma P; Chen Y; An C; Sun L
    J Cell Biochem; 2019 Mar; 120(3):4423-4432. PubMed ID: 30367526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circ_0009910 sponges miR-491-5p to promote acute myeloid leukemia progression through modulating B4GALT5 expression and PI3K/AKT signaling pathway.
    Wu Y; Zhao B; Chen X; Geng X; Zhang Z
    Int J Lab Hematol; 2022 Apr; 44(2):320-332. PubMed ID: 34709725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of MACF1 on acute myeloid leukemia cell proliferation is involved in Runx2-targeted PI3K/Akt signaling.
    Wang P; Zhang J; Zhang H; Zhang F
    Mol Cell Biochem; 2023 Mar; 478(3):433-441. PubMed ID: 35857251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of Long Non-Coding RNA LINC01268 on the Malignant Biological Behaviors of Acute Myeloid Leukemia Cells].
    Chen W; Gan DY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Dec; 31(6):1608-1616. PubMed ID: 38071035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N6-methyladenosine-modified SENP1, identified by IGF2BP3, is a novel molecular marker in acute myeloid leukemia and aggravates progression by activating AKT signal via de-SUMOylating HDAC2.
    Wen D; Xiao H; Gao Y; Zeng H; Deng J
    Mol Cancer; 2024 May; 23(1):116. PubMed ID: 38822351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.